期刊文献+

肥胖人群前列腺体积比较分析 被引量:4

Prostate volume in obesity people
原文传递
导出
摘要 目的探讨肥胖与男性良性前列腺增生(BPH)的关系。方法入选253例40岁以上健康体检男性,经询问病史,测身高、体重、腰围、体脂肪率、血压、空腹血糖、血脂及前列腺B超,排除肥胖相关性疾病,按体质指数(BMI)分为正常组(18.5~23.9kg/m^2)、超重组(24.0~27.9kg/m^2)及肥胖组(≥28kg/m^2),按腰围分为正常组(〈85cm)及腹型肥胖组(≥85cm),按体脂肪率分为正常组(≤25%)及超标组(〉25%),分析各组前列腺体积的差异,组间比较使用t检验及χ2检验。结果BMI正常组前列腺体积为(18.2±6.1)ml,超重组为(21.6±6.3)ml,肥胖组为(24.9±7.6)ml,正常组与超重组、肥胖组比较,差异有统计学意义。腰围正常组前列腺体积为(20.65.6)ml,腹型肥胖组为(23.5±6.2)ml,两组比较差异有统计学意义。体脂肪率正常组前列腺体积为(19.6±6.5)ml,超标组为(23.9±5.3)ml,两组比较前列腺体积差异有统计学意义。BMI、腰围及体脂肪率高的人群前列腺体积更大。BMI≥24kg/m^2人群中腰围正常或者体脂肪率正常人群,BPH发生率并无明显增高。结论肥胖是BPH的危险因素;腰围及体脂率超标者,发生BPH危险性更高。 Objective To investigate the association between obesity and benign prostate hyperplasia (BPH). Methods A total of 253 men ( 〉 40 year-old) with no obesity-related diseases were selected. Medical history, height, body weight, waist circumference ( WC ), body fat ratio, blood pressure, fasting blood glucose, blood lipid and prostate ultrasound were evaluated. The participants were then assigned to the normal group (body mass index 18.5 to 23.9 kg/m2) ,overweight group (24. 0 to 27. 9 kg/m2) and obesity group ( ≥ 28 kg/m2 ). The subjects were also divided into the normal group ( WC 〈 85 cm ) and abdominal obesity group (WC ≥ 85 cm) or normal group (body fat ratio ≤25% ) and excessive body fat ratio group ( 〉 25% ) . Prostate volume was analyzed in each group. Results The prostate volume was significantly different between the normal body mass index group and overweight or obesity groups, normal WC group and abdominal obesity group, and normal body fat ratio group and excessive body fat ratio group. The prostate volume was increased in individuals with higher body mass index, WC and body fat ratio. Of those with body mass index≥24 kg/m2 and normal WC or body fat ratio,the incidence of BPH was not significantly increased. Conclusion Obesity may be a risk factor for BPH; individuals with increased WC and body fat ratio may have a higher risk of BPH.
出处 《中华健康管理学杂志》 CAS 2011年第3期134-136,共3页 Chinese Journal of Health Management
基金 广东省科技计划项目(2007B031511002)
关键词 肥胖症 体质 前列腺 Obesity Body constitution Prostate
  • 相关文献

参考文献9

  • 1National Heart, Lung, and Blood Institute in cooperation with The National Institutes of Diabetes and Digestive and Kidney Diseases. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Reporl. Bethesda, MD : National Institutes of Health, 1998.
  • 2Rowhrborm CG, McConnell JD. Etiology, pathothysiology, epidemiology and natural history of benign prostatic hyperplasia. In: Campbell's Urology. Edited by PC Walsh, AB Retik, ED Vaughan Jr and AJ Wein Philadelphia, PA: W. B. Saunders Company,2002 : 1297-1330.
  • 3朱智明.肥胖症//朱智明,俞金龙.肥胖症的最新治疗.北京:人民军医出版社,2007:1-30.
  • 4Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults( Adult Treatment Panel Ⅲ )final repert. Circulation ,2002,106 : 3143-3421.
  • 5Soygur T,Kupeli B,Aydos K,et al. Effect of obesity on prostatic hyper-plasia: its relation to sex steroid levels. Int Urol Nephrol, 1996,28:55-59.
  • 6Daniell HW. Larger prostatic adenomas in obese men with no associated in-crease in obstructive uropathy. Urology, 1993,149: 315-317.
  • 7Lee S, Min HG, Choi SH, et al. Central obesity as a risk factor for prostatic hyperplasia. Obesity ,2006,14 : 172-179.
  • 8何家扬,王伟.代谢综合征与前列腺增生症[J].现代泌尿外科杂志,2009,14(2):81-83. 被引量:9
  • 9中华医学会健康管理学分会 中华健康管理学杂志编委会.健康管理概念与学科体系的中国专家初步共识[J].中华健康管理学杂志,2009,3:141-147.

二级参考文献14

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3059
  • 2OZDEN C, OZDAL OL, URGANCIOGLU G, et al. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia [J]. Eur Urol, 2007, 51(1) :199-206.
  • 3HAMMASTEN J, HOGSTED B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia [J ]. Eur Urol, 2001, 39(2):151-158.
  • 4NANDEESHA H, KONER BC, DORAIRAJAN LN, et al. Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia[J]. Clinica Chimica Acta, 2006,370(1-2) :89-93.
  • 5BURKE JP, JACOBSON DJ, MCGREE ME, et al. Diabetes and benign prostatic hyperplasia progression in Olmsted county, Minnesota[J]. Urology, 2006,67(1) : 22-25.
  • 6SOURIJ H, SCHMOELZER I, DITTRICH P, et al. Insulin resistance as a risk factor for carotid atherosclerosis:a comparison of the Homeostasis Model Assessment and the short insulin tolerance test [J]. Stroke, 2008, 39(4) :1349-1351.
  • 7LEE S, MIN HG, CHOI SH, et al. Central obesity as a risk factor for prostatic hyperplasia [J]. Obesity, 2006,14 (1):172- 179.
  • 8KASTURI S, RUSSELL S, MCVARY KT. Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia [J].Curr Urol Rep, 2006,7 (4) : 288-292.
  • 9ALBERTI KG, ZIMMET P, SHAW J, et al. The metabolic syndrome-- a new worldwide definition[J]. Lancet, 2005, 366 (9491) : 1059-1062.
  • 10BALKAU B, ESCHWEGE E. The metabolic syndrome [J]. Lancet, 2005, 366(9501) :1921.

共引文献92

同被引文献123

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部